Li Q - Search Results

1

Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.

Prince MEP, Zhou L, Moyer JS, Tao H, Lu L, Owen J, Etigen M, Zheng F, Chang AE, Xia J, Wolf G, Wicha MS, Huang S, Ren X, Li Q. Prince MEP, et al. Among authors: li q. Oral Oncol. 2016 Aug;59:30-42. doi: 10.1016/j.oraloncology.2016.05.013. Oral Oncol. 2016. PMID: 27424180 Free PMC article.

2

Therapeutic effects of tumor reactive CD4+ cells generated from tumor-primed lymph nodes using anti-CD3/anti-CD28 monoclonal antibodies.

Li Q, Yu B, Grover AC, Zeng X, Chang AE. Li Q, et al. J Immunother. 2002 Jul-Aug;25(4):304-13. doi: 10.1097/00002371-200207000-00002. J Immunother. 2002. PMID: 12142553

3

Generation of vaccine-primed lymphocytes for the treatment of head and neck cancer.

Chang AE, Li Q, Jiang G, Teknos TN, Chepeha DB, Bradford CR. Chang AE, et al. Among authors: li q. Head Neck. 2003 Mar;25(3):198-209. doi: 10.1002/hed.10195. Head Neck. 2003. PMID: 12599287

4

Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer.

Chang AE, Li Q, Jiang G, Sayre DM, Braun TM, Redman BG. Chang AE, et al. Among authors: li q. J Clin Oncol. 2003 Mar 1;21(5):884-90. doi: 10.1200/JCO.2003.08.023. J Clin Oncol. 2003. PMID: 12610189 Clinical Trial.

5

Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.

Li Q, Carr A, Ito F, Teitz-Tennenbaum S, Chang AE. Li Q, et al. Cancer Res. 2003 May 15;63(10):2546-52. Cancer Res. 2003. PMID: 12750278

6

Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine model.

Ito F, Carr A, Svensson H, Yu J, Chang AE, Li Q. Ito F, et al. Among authors: li q. J Immunother. 2003 May-Jun;26(3):222-33. doi: 10.1097/00002371-200305000-00006. J Immunother. 2003. PMID: 12806276

7

Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.

Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE. Teitz-Tennenbaum S, et al. Among authors: li q. Cancer Res. 2003 Dec 1;63(23):8466-75. Cancer Res. 2003. PMID: 14679011

8

Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines.

Ito F, Li Q, Shreiner AB, Okuyama R, Jure-Kunkel MN, Teitz-Tennenbaum S, Chang AE. Ito F, et al. Among authors: li q. Cancer Res. 2004 Nov 15;64(22):8411-9. doi: 10.1158/0008-5472.CAN-04-0590. Cancer Res. 2004. PMID: 15548712

9

Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern.

Li Q, Carr AL, Donald EJ, Skitzki JJ, Okuyama R, Stoolman LM, Chang AE. Li Q, et al. Cancer Res. 2005 Feb 1;65(3):1063-70. Cancer Res. 2005. PMID: 15705908

10

Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.

Li Q, Grover AC, Donald EJ, Carr A, Yu J, Whitfield J, Nelson M, Takeshita N, Chang AE. Li Q, et al. J Immunol. 2005 Aug 1;175(3):1424-32. doi: 10.4049/jimmunol.175.3.1424. J Immunol. 2005. PMID: 16034078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,930 results

Search Page

Filters